Evaluation of the Efficacy of Pulmonary Vein Isolation by Pulsed-field Ablation in Persistent Atrial Fibrillation: a Multicenter Study With Follow-up by Implantable Cardiac Monitor

Inclusion Criteria: * Symptomatic persistent AF (continuous episode sustained beyond 7 days) * Refractory, intolerant or unwilling to take ADT * Signed informed consent * Affiliation to medical social coverage. Non inclusion Criteria: * Persistent long-term atrial fibrillation with ongoing episode continuous for more than 3 years; * Left ventricular ejection fraction ≤ 15% ; * Stage IV of the New York Heart Association classification; * Previous atrial ablation outside the cavotricuspid isthmus; * Wearer of an implantable electronic cardiac prosthesis (pacemaker or defibrillator; MCI) * Hypertrophic heart disease other than hypertensive hypertrophic heart disease; * Severe valvular heart disease, including the presence of a mechanical mitral valve or any mitral surgery; * Congenital heart disease, including atrial septal defect, patent foramen ovale treated by percutaneous closure with atrial septal prosthesis; * Presence of cardiac thrombus; * Myocardial infarction or percutaneous coronary angioplasty within the last 6 months; * Cardiac surgery within the last 6 months; * Systemic thromboembolic event less than 6 months ago; * Pulmonary embolism less than 6 months ago or pulmonary hypertension requiring specific treatment; * Inability to read independently * Vulnerable patient: minor, patient under curatorship or guardianship